February 2018 - Page 3 of 3 - CanadianCannabisWire

ThursdayFeb 01, 2018 3:29 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Teams with UniQuest to Develop Novel Cannabinoid Delivery System

Global nasal drug delivery technology market expected to reach $64 billion by 2021 Development of CBD-infused soluble gel for nasal delivery targets range of diseases Clinical benefits of Sol-gel delivery method include a safer, more reliable delivery platform with higher efficacy Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and UniQuest Pty Limited, the main commercialization company of the University of Queensland (UQ), Australia, are expecting 2018 to be an exciting, productive year for joint medical research projects. PreveCeutical Medical, headquartered in Vancouver, British Columbia, has entered into a research and option agreement with the University and…

ThursdayFeb 01, 2018 12:04 pm

Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) Subsidiary Receives First Genetics at Ontario Plant-Growing Facility

Company plans mid-2018 commencement of adult-use market sales in Canada as it addresses medical segment opportunity The firm received its cultivation license during the fourth quarter of 2017, anticipates receiving its sales license by May Phillip Millar, MMG president, said company’s portfolio includes genetic strain that holds the highest level of CBD in Canada, sees potential in medical segment and for European export Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) recently announced that its subsidiary, Medical Marijuana Group ("MMG"), has received its first order of genetics at its St. Thomas, Ontario facility as it transitions from a production location…